August 2022 aTen Therapeutics awarded £282k Innovate UK grant to develop new breast cancer treatment.
aTen Therapeutics relocates to new offices at 1 Lochrin Square, Fountainbridge, Edinburgh EH3 9QA.
Ian Abercrombie appointed Chief Executive Officer at aTen Therapeutics.
1 Lochrin Square, Fountainbridge, Edinburgh EH3 9QA
+44 (0) 131 357 4251